Human medicines European public assessment report (EPAR): Foclivia, pandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted), Influenza, Human;Immunization;Disease Outbreaks, Date of authorisation: 18/10/2009, Revision: 13, Status: Au

Human medicines European public assessment report (EPAR): Foclivia, pandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted), Influenza, Human;Immunization;Disease Outbreaks, Date of authorisation: 18/10/2009, Revision: 13, Status: Authorised